Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-CSF1R, SNDX-6352 Vector   (CAT#: GTVCR-WQ2513MR)

This product GTVCR-WQ2513MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting CSF1R. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Humanized
RefSeq NM_001288705.3
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 1436
UniProt ID P07333
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-CSF1R, SNDX-6352 Vector (GTVCR-WQ2513MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1607MR IVTScrip™ pT7-VEE-mRNA-Anti-VSIR, JNJ-61610588 Vector Vector JNJ-61610588
GTVCR-WQ1131MR IVTScrip™ pT7-VEE-mRNA-Anti-EGFR, DS 992 Vector Vector DS 992
GTVCR-WQ1231MR IVTScrip™ pT7-VEE-mRNA-Anti-VTCN1, FPA-150 Vector Vector FPA-150
GTVCR-WQ1728MR IVTScrip™ pT7-VEE-mRNA-Anti-ERBB3, LJM716 Vector Vector LJM716
GTVCR-WQ1317MR IVTScrip™ pSP6-VEE-mRNA-Anti-RTN4, GSK-1223249 Vector Vector GSK-1223249
GTVCR-WQ449MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL2RB, AMG 592 Vector Vector AMG 592
GTVCR-WQ2004MR IVTScrip™ pT7-VEE-mRNA-Anti-ERBB3&IGF1R, MM-005 Vector Vector MM-005
GTVCR-WQ827MR IVTScrip™ pT7-VEE-mRNA-Anti-TNFRSF17, C11D5.3 scFv-8A-F9Z CAR Vector Vector C11D5.3 scFv-8A-F9Z CAR
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.